Hubei Haoxin Pharmaceutical Co., Ltd
Hubei Haoxin Pharmaceutical Co., Ltd. is a Sino Hong Kong joint venture enterprise that integrates research, development, and production of original Chinese and Western medicine preparations and pharmaceutical intermediates. The company was establish
Introduction
Hubei Haoxin Pharmaceutical Co., Ltd. is a Sino Hong Kong joint venture enterprise that integrates research, development, and production of original Chinese and Western medicine preparations and pharmaceutical intermediates. The company was established in February 2003 with a registered capital of 8 million US dollars Erythromycin Huyi, Epistine Hydrochloride, Amisulpride, Irinotecan Hydrochloride, Anhydrous Paclitaxel, Dasatinib, Temozolomide, Granisetron Hydrochloride, Hubei Haoxin Pharmaceutical Co., Ltd
Information
Categories
More Websites
Today's advances in man-made nanomaterials pose new and unprecedented risks to employees along the whole value chain. Airborne, inhalable fiber-shaped nanomaterials like carbon nanotubes (CNTs) and graphene nanoplatelets (GNPs) can pose asbestos-like
We are a global provider of industry-leading foam & system solutions and sustainable innovations for the mobility, industrial, medical and living & care sectors.
As of April 1st 2021, FoamPartner is part of Recticel and, together with the ...